Physician profile
Liem Trang
NPI 1619084738
$5,928.60
in general payments reported to CMS, 2019-2025
25 companies · $306 in 2025
The $306 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,479 · 2020: $233 · 2021: $294 · 2022: $1,659 · 2023: $1,072 · 2024: $884 · 2025: $306.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,233 · Education: $29.08.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,233.15 |
| Education | $29.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,495.65 | 2021-2025 | Intellis Adaptivestim, Synchromedii, Accurian |
| Relievant Medsystems, INC. | $1,350.19 | 2022-2023 | Intracept |
| Medtronic USA, INC. | $772.72 | 2019-2020 | |
| Boston Scientific Corporation | $332.39 | 2020-2024 | Intracept |
| Mml US, INC. | $185.85 | 2023 | Reactiv8 |
| Nevro Corp. | $169.94 | 2019-2021 | |
| Saluda Medical Americas, INC. | $163.41 | 2023 | Evoke Scs |
| Stratus Medical, LLC | $150.47 | 2023 | Nimbus |
| Abbott Laboratories | $145.51 | 2019 | |
| Baudax Bio INC. | $144.20 | 2022 | |
| Zimvie INC. | $125.36 | 2022 | |
| Pacira Therapeutics, INC. | $111.23 | 2019 | |
| Biodelivery Sciences International, INC. | $109.40 | 2019 | |
| Daiichi Sankyo INC. | $105.66 | 2019 | |
| Spr Therapeutics, INC | $102.02 | 2025 | Sprint Pns System |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $99.83 | 2019 | |
| Collegium Pharmaceutical, INC. | $78.25 | 2022-2024 | Belbuca |
| Orthofix Medical, INC. | $63.60 | 2024 | Mariner |
| Spinal Simplicity, LLC | $51.86 | 2024 | Ha Minuteman G3-R |
| Stryker Corporation | $49.73 | 2020 | |
| Novartis Pharmaceuticals Corporation | $40.64 | 2020 | |
| Omeros Corporation | $29.32 | 2019-2020 | |
| Biogen, INC. | $23.73 | 2020 | |
| Lilly USA, LLC | $15.34 | 2019 | |
| Almatica Pharma LLC | $12.30 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Liem Trang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.